PunchClimate, health actions could save 1.6 million lives yearly — WHODaily MaverickWHAT’S COOKING: Sweet and sour pork with lycheesInquirerQuezon vice gov urges youth to emulate Hermano Puli’s patriotismThe Jerusalem PostShin Bet, police arrest senior Balad activist Abd Abu Shahada over suspected security offensesBollywood HungamaRam Kamal Mukherjee wins Best Director at the 11th International Indian Film Festival of Toronto for Lokkhikantopur LocalSky TG24Elezioni Usa Midterm 2026, chi sono gli eletti alla Camera e al Senato. FOTONumeramaAprès les supermarchés, une cyberattaque menace les réserves de plasma de l’Établissement français du sangNotJustOkBruno Fernandes reacts to Manchester United’s victory over AS RomaInquirer EntertainmentToto to take timeless hits back to the Philippines in 2027 concertsThe Times of IsraelTrump, conceding stunning midterm loss, admits Iran war and gas prices hurt RepublicansNU.nlKiescommissie Israël verwerpt beschuldigingen van verkiezingsfraudeThe Straits TimesMore S’pore university, polytechnic graduates land jobs by the one-year mark after leaving school
The Daily Newsstand · Free, Always
Wednesday, November 4, 2026

Indonesia, WHO bolster herbal medicine control to tap economic benefit

Translate

Jakarta (ANTARA) - The Indonesian government and the World Health Organization (WHO) have partnered to strengthen post-market surveillance of traditional medicines and health supplements, aiming to ensure consumer safety and unlock the country's bioeconomic potential.

Speaking at a capacity-building workshop in Jakarta on Tuesday, Food and Drug Authority (BPOM) Head Taruna Ikrar highlighted Indonesia's vast biodiversity, noting the country possesses approximately 31,000 plant species with potential medicinal applications.

Ikrar highlighted jamu, Indonesia’s traditional herbal wellness system inscribed on UNESCO's Intangible Cultural Heritage list, noting that BPOM has issued around 27,000 distribution permits for natural medicinal products.

He said the global traditional medicine market is projected to reach US$606 billion, with Indonesia's domestic market potential estimated at US$20 billion.

"However, our latest data indicates that the realized market value in Indonesia currently stands at just under Rp6 trillion (approximately US$330.91 million)," Ikrar said, pointing to a vast untapped commercial opportunity.

He emphasized that bridging this gap requires addressing safety challenges, particularly the illicit adulteration of traditional remedies with synthetic chemical drugs, which poses severe public health risks including organ failure and chronic complications.

"While the market opportunities and health benefits are immense, BPOM bears the fundamental duty of ensuring robust oversight so that all products in circulation are strictly monitored and safe for consumption," Ikrar said.

The WHO-backed workshop gathered regional BPOM officers to bolster post-market surveillance protocols across the archipelago.

WHO Indonesia National Professional Officer for Essential Drugs and Medicines Liyana Rakinaturia said the partnership is expected to boost BPOM’s regulatory capacity.

Rakinaturia stressed the importance of aligning national monitoring mechanisms with WHO global benchmarks, particularly regarding post-market safety surveillance of traditional and herbal remedies.

Related news: BPOM supports health tourism with special herbal medicine access

Related news: Indonesia eyes global wellness leadership through jamu industry

Translator: Mecca Yumna, Uyu Liman
Editor: Arie Novarina
Copyright © ANTARA 2026

View the original on Antara News →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.